1. Peculiarities in cases of spina bifida cystica managed recently in south-east Nigeria: could antimalarial drugs be a major but unrecognized etiologic factor?
- Author
-
Emejulu JK and Okwaraoha BO
- Subjects
- Child, Preschool, Female, Folic Acid Deficiency chemically induced, Folic Acid Deficiency epidemiology, Folic Acid Deficiency etiology, Humans, Infant, Infant, Newborn, Male, Nigeria epidemiology, Pregnancy, Pregnancy Trimester, First, Prenatal Exposure Delayed Effects etiology, Prospective Studies, Risk Factors, Spinal Dysraphism etiology, Antimalarials adverse effects, Prenatal Exposure Delayed Effects chemically induced, Prenatal Exposure Delayed Effects epidemiology, Spinal Dysraphism chemically induced, Spinal Dysraphism epidemiology
- Abstract
Background: Spina bifida is a long-known disease arising from the incomplete fusion of the caudal neuropore in the first month of intrauterine life. It is thought to have a multifactorial etiology, the most important of which is folic acid deficiency. In evaluating its etiology, the role of antifolate agents like antimalarial drugs is rarely given a strong mention., Methods/patients: This is a 44-month prospective study of consecutive cases of spina bifida cystica presenting to the Neurosurgery Unit of Nnamdi Azikiwe University Teaching Hospital, Nnewi, South-East Nigeria. Data collection was with a structured proforma from presentation, and collation done with Microsoft Excel broadsheet and data analysis with SPSS and χ2 test., Results: A total of 41 cases of spina bifida were attended to within the period, with 92.7% cases of spina bifida cystica. Most presented by >12-24 months, with a consistent history of maternal ingestion of antimalarial drugs during the first trimester of pregnancy., Conclusion: Spina bifida cystica was diagnosed mostly in children whose mothers ingested antimalarial drugs during the first trimester of gestation. There may be a need to critically evaluate the contribution of antimalarial drugs to the etiopathogenesis of this malformation and develop safer antimalarial treatment in pregnancy., (Copyright © 2012 S. Karger AG, Basel.)
- Published
- 2011
- Full Text
- View/download PDF